NorthWest Georgia Oncology Centers NW Georgia Oncology is a clinical research site located in Marietta, Georgia, United States 30060.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
NorthWest Georgia Oncology Centers NW Georgia Oncology has participated in 3 clinical trials.
Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib, Tumors With CDK4/6 Pathway Activation, Solid Tumor.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NorthWest Georgia Oncology Centers NW Georgia Oncology has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NorthWest Georgia Oncology Centers NW Georgia Oncology has 3 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib, Tumors With CDK4/6 Pathway Activation, Solid Tumor.
NorthWest Georgia Oncology Centers NW Georgia Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.